Table 5 Univariate and multivariate analysis of HCV risk factors for people living with HIV, Cambodia, 2016
Characteristics | Anti HCV positive | Unadjusted | Adjusteda | ||||||
|---|---|---|---|---|---|---|---|---|---|
n = 29 | % | OR (CI 95%) | P | OR (CI 95%) | P | ||||
Age group, years | |||||||||
18–30 | 1 | 3.57 | Ref. | Ref. | |||||
31–40 | 7 | 5.11 | 1.45 [0.17–12.30] | 1.42 [0.15–12.77] | |||||
> 40 | 21 | 8.00 | 2.37 [0.30–18.33] | 0.20 | 2.52 [0.30–20.88] | 0.28 | |||
Sex | |||||||||
Male | 13 | 6.88 | Ref. | Ref. | |||||
Female | 16 | 6.78 | 0.98 [0.46–2.10] | 0.97 | 0.89 [0.38–2.03] | 0.78 | |||
Ever received intravenous medication in the past 5 years | |||||||||
No | 1 | 1.05 | Ref. | Ref. | |||||
Yes | 28 | 8.48 | 8.71 [1.17–64.91] | 0.04 | 7.67 [1.01–57.84] | 0.048 | |||
Having a family member positive for HCV | |||||||||
No | 20 | 5.08 | Ref. | Ref. | |||||
Yes | 9 | 29.03 | 7.65 [3.12–18.75] | < 0.001 | 7.10 [2.79–18.10] | < 0.001 | |||